Peer Review History
| Original SubmissionJune 25, 2019 |
|---|
|
Transfer Alert
This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.
PONE-D-19-18040 California Condor Microbiomes: Bacterial Variety and Functional Properties in Captive-Bred Individuals PLOS ONE Dear Dr. Fair, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Both the reviewers and I think the manuscript has a lot of merit, although a number of changes were recommended. In particular, there are some places in the manuscript that could be removed to shorten it, such as the description of sequencing in the introduction. This may help to better focus the paper. We would appreciate receiving your revised manuscript by Sep 10 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Suzanne L. Ishaq, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 1. Thank you for including your competing interests statement; "The authors have declared that no competing interests exist." We note one ore more authors are affiliated to Viome, and GenerisBio.
Please also include the following statement within your amended Funding Statement. “The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.” If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement. 2. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc. Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests). If this adherence statement is not accurate and there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf. Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Dear authors, I have had the pleasure of reviewing your paper for the second time, and want to thank you for taking my previous comments into account. The manuscript shows interesting and important results by comparing different sequencing methods in microbiomes of captive condors. I have a few overall comments, and below specific, line by line comments. Overall, it is important to mention early in the manuscript that metagenomic sequencing represents potential functional profiles, and not functions actually occurring at the time of sampling. This is mentioned somewhere in the discussion, but should be moved up. Also, use of the word species for bacteria is complicated. If the authors used OTUs for clustering of 16S reads, they should be referred to as such. I hope my comments help improve the manuscript. Sincerely, Kirsten Grond Introduction The introduction is very thorough, which makes it long. If this is not a problem with the journal, leave it like this. If it is, you could possibly move part of the sequencing description in L114-126 to the methods section Results: L139. Add references or discuss this in the Discussion instead. L168-170. Remove this sentence, as this information is in the figure description. L172-174. Back this statement up with alpha diversity metrics & statistics. L177-183. Can be moved to figure description. L188-189. Remove this sentence L198-202. Move to figure description L204-206. Move to methods L207. polymerase L208-211. If matches are only to genus level, mention genus only and do not pick a well-known species instead (if I understood this right). Using a species that is potentially incorrect misrepresents results. L212-216. The authors should not use rarefaction curves to say anything about diversity. Alpha diversity metrics with appropriate statistical tests should be used. L217-220. Not necessary to describe what was done. Just report results. L222. Test statistic for permanova is R2. L222-224. Instead of using permanova for pairwise comparisons I would suggest using TukeyHSD. When eliminating a variable from permanovas/changing order of variables the results change. L234-235. Seems more like a methodological discussion point than a result L235-236. If the sequencing was deep enough (>100x coverage) and assembled, the authors can check the alignment rate of the raw reads back to the contigs or bins, and the alignment rate would tell if they are getting fine scaled phylogenies. For example, an alignment rate of >90% would be good and likely include most members of the community. A low alignment rate of <50% would indicate incomplete coverage and phylogenies will be missing a large portion of the communities. L238-244. Move to methods. L244-246. Move to figure caption or delete. Only report the results from the analyses here. L249. Based on Delftia strain ID? L251-254. I am unsure what the goal of this paragraph is. State the main findings of figure 4b instead? L257-258. Remove sentence. L262-263. Move this topic to discussion L264-266. What do the authors mean by polarized extremes? L271. Birds-eye! :D L272-275. Move to figure description L283-289. Seems more appropriate in methods. Also the first mention of the genes investigated, which should definitely be in the methods. Discussion The discussion is thorough, but very long. It contains several paragraphs that are part method or can be omitted. I indicated below which sections can potentially be removed. L301. The authors should be consistent in terminology. Metagenomics is also used as a term for 16S in the manuscript, which could be confusing. L302-304. Sentence needs clarification L306-308. Do you know anything about Delftia genome size? If they have large genomes, that could also explain the difference in detection between the methods. Also, sequencing depth is much larger in the metagenomics. L313-315. I don’t think this sentence is necessary. L321-327. Good points! L329-330. Some members of the classes are pathogenic, not the whole class. L330-332. Merge these sentences to improve flow. L333. Fusobacteria L332-348. Super cool that physiology is so selective! L364-365. Remove sentence L371-373. This is a good thing to mention, but would fit better in a paragraph discussing the differences between fecal and cloacal samples. L374-376. Would not report a math on 93% similarity. At most that is a genus level match. L387-397. This describes methods and can be removed from the discussion L398-403. Rewrite this paragraph with alpha diversity results. L405-409. Can be removed L414. Grained L430-431. Remove sentence L440-441. Remove sentence or explain the concepts. L442-452. This would be useful to move to methods, where signatures are explained. L455-463. This section should be in the Results as it states results but does not explain/discuss them. L464-466. Methods L467-478. This paragraph does not appear to add much to the discussion, and could be removed in the interest of shortening this section. Conclusion L480. Sentence reads funky. L485-486. Use as first sentence of the paragraph and include main finding. L500-502. Remove sentence. More samples are always needed, but the authors have a nice sample set here and the last sentence of the manuscript should not take away from that. Methods L542-543. Potential PCR bias in low DNA samples because of the different cycle numbers? Is cycle number a significant predictor for microbiome diversity/community composition? L554-560. Add degree symbol for C L569-570. Need a lot more information on analysis parameters here. Which programs were used for trimming, assembly, annotation, references etc. Did the authors align the raw reads to the TOL database and use those annotations for taxa? If so, there likely are a large number of false ID’s. To avoid this problem, the authors could assemble their reads, and align to that assembly. Any reads that don’t align to those contigs can be annotated for function separately, but should not be trusted for taxa info. L600. Did the authors look if results changes using other distance matrices? Maybe add to supplement? L606. Is Delftia a genus or species? Which genes did you look at? L611. Expand the 16S analyses section. Which OTU-picking strategy and reference database did you use? What % was used for OTU cutoff? Figures Overall: - Non-gradient colors would make the graph easier to read Figure 1 - The labeling on the graph is confusing. There are places with two bacteria per color, and it is unclear whether this is a mistake or if the class is split between them. Would recommend to change the colors (or overlay with pattern) and add separate legend for the most abundant species. - Add label to y-axis. - In the caption it is mentioned that species were identified with among others16S data, which does not have the resolution for species identification. Figure 2 - Why does not every row have something assigned to it? It is difficult to see which species corresponds with what data in the way this figure is presented. Also, expand the figure so full bacterial names are on one line and italicize them. I still don’t understand why the condor reads are in this figure. What does that add to the paper? Figure 3 - Move to supplement. Not essential for main manuscript. Figure 5A - label y-axis Figure 5C - Move the legend to not overlap with the bars in the graph. Figure 6 - increase symbol size and make text more readable. Figure S3. - What do the different colors mean? Reviewer #2: To authors: This paper utilizes two analyses methods to compare the microbiome of cloacal and fecal samples of captive California condors. The strengths of this text are 1. It provides baseline knowledge of how a scavenging bird’s microbiome looks like. 2. It demonstrates that the different analyses approaches can potentially produce dissimilar results. Simple and straightforward writing is not a strength of this text and authors should make an effort to improve the readability of the paper. I hope that this manuscript motivates further research into host-associated microbes in wild scavenger birds. General comments: 1. My main and only big criticism is that you could have used additional variables to explain the observed patterns. It is well known that sex and breeding status con affect the microbiome. Is there a chance you could rerun some of the analyses to further explain your results including at least sex of the bird? 2. Your discussion would benefit if you provide further information on the bacterial transmission/colonization processes of these birds. Specific comments. (L=line) 1. L43: Provide a broader conclusion 2. L49: Should be decade 3. Figure 1: Why are there random bacterial names on top of the bacterial groups? They make the figure harder to read. 4. L180-181: This belongs in the figure legend. 5. L199: Willing to make? I don’t understand. 6. Figure 3: Title is not necessary 7. Figure 3: Why are all the rarefaction curves cut at the same number of sampled sequences? 8. Figure 3: Could you provide the variance in the curves? 9. L258: delete the first are 10. L296-300: Can you provide hypotheses as to why immature condors have a more diverse microbiome? 11. L360-362: Could you provide a reference here? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Kirsten Grond Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
California Condor Microbiomes: Bacterial Variety and Functional Properties in Captive-Bred Individuals PONE-D-19-18040R1 Dear Dr. Fair, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Suzanne L. Ishaq, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Overall, I am happy with how the authors have addressed my comments. I have reviewed this manuscript for a different journal before reviewing it for PLoS, and the authors have done a great job at addressing all comments. Please congratulate them from me on their effort and a great manuscript. Reviewer #2: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Kirsten Grond Reviewer #2: No |
| Formally Accepted |
|
PONE-D-19-18040R1 California Condor Microbiomes: Bacterial Variety and Functional Properties in Captive-Bred Individuals Dear Dr. Fair: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Suzanne L. Ishaq Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .